Status:
COMPLETED
A Study to Evaluate Clinical Characteristics of Lung Cancer in Patients With Surgeries and Adjuvant Therapies
Lead Sponsor:
West China Hospital
Collaborating Sponsors:
LinkDoc Technology (Beijing) Co. Ltd.
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The study was designed to evaluate effectiveness of the surgeries and adjuvant therapies after surgeries in the patients with lung malignant tumors
Detailed Description
The trial is a multi-centre real-world non-interventional observational study to evaluate effectiveness of the surgeries and adjuvant therapies after surgeries in the patients with lung malignant tumo...
Eligibility Criteria
Inclusion
- Age \>= 18 years old;
- Pathologically diagnosed lung malignant tumors after surgeries;
- Patients with lung surgeries;
- Patients with complete medical health records and follow-up visit information (at least one follow-up visit);
Exclusion
- Patients who were not performed with surgeries;
- Pathologically diagnosed patients with benign diseases after surgeries;
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2018
Estimated Enrollment :
21777 Patients enrolled
Trial Details
Trial ID
NCT03421093
Start Date
December 1 2017
End Date
March 30 2018
Last Update
May 21 2018
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China, 100029
2
China PLA General Hospital
Beijing, Beijing Municipality, China, 100853
3
Henan cancer hospital
Zhengzhou, Henan, China, 450008
4
Tongji Hospital Affiliated to Huaxi Technology University
Wuhan, Hubei, China, 430030